Novo Nordisk opens the books for the previous quarter.
Novo Nordisk will publish its balance sheet for the most recent quarter ended September 30, 2025 on November 5th, 2025.
On average, 13 analysts expect quarterly earnings per share of DKK 4.90. In the same quarter last year, the company reported a profit of DKK 6.13 per share.
On the sales side, 14 analysts are forecasting an increase of 7.31 percent compared to the same quarter of the previous year. On average, analysts expect sales of DKK 76.53 billion. In the same period last year, the company had sales of DKK 71.31 billion.
In total, 26 analysts expect an average profit of DKK 23.60 per share for the current fiscal year, compared to DKK 22.67 per share in the previous year. 25 analysts put annual sales at an average of DKK 313.02 billion. In the previous year there were still 290.40 billion DKK on the books.
Editorial team finanzen.net
Selected leverage products on Novo Nordisk
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Novo Nordisk
The leverage must be between 2 and 20
Advertising